Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections

被引:19
作者
Shaikh, Safia Bader Uddin [1 ]
Ahmed, Zafar [1 ]
Arsalan, Syed Ali [1 ]
Shafiq, Sana [1 ]
机构
[1] Liaquat Natl Hosp, Dept Pulmonol, Karachi, Pakistan
来源
INFECTION AND DRUG RESISTANCE | 2015年 / 8卷
关键词
community-acquired lower respiratory tract infections or pneumonia; M; catarrhalis; antibiotic resistance; gram-negative diplococcic; Pakistan; OBSTRUCTIVE PULMONARY-DISEASE; ANTIMICROBIAL RESISTANCE; HAEMOPHILUS-INFLUENZAE; ACUTE EXACERBATIONS; PNEUMONIA; CHILDREN; COPD;
D O I
10.2147/IDR.S84209
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Moraxella catarrhalis previously considered as commensal of upper respiratory tract has gained importance as a pathogen responsible for respiratory tract infections. Its beta-lactamase-producing ability draws even more attention toward its varying patterns of resistance. Methods: This was an observational study conducted to evaluate the prevalence and resistance pattern of M. catarrhalis. Patients aged 20-80 years admitted in the Department of Chest Medicine of Liaquat National Hospital from March 2012 to December 2012 were included in the study. Respiratory samples of sputum, tracheal secretions, and bronchoalveolar lavage were included, and their cultures were followed. Results: Out of 110 respiratory samples, 22 showed positive cultures for M. catarrhalis in which 14 were males and eight were females. Ten samples out of 22 showed resistance to clarithromycin, and 13 samples out of 22 displayed resistance to erythromycin, whereas 13 showed resistance to levofloxacin. Hence, 45% of the cultures showed resistance to macrolides so far and 59% showed resistance to quinolones. Conclusion: Our study shows that in our environment, M. catarrhalis may be resistant to macrolides and quinolones; hence, these should not be recommended as an alternative treatment in community-acquired lower respiratory tract infections caused by M. catarrhalis. However, a study of larger sample size should be conducted to determine if the recommendations are required to be changed.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 50 条
  • [21] Use of antimicrobial agents for community-acquired lower respiratory tract infections in hospitalised children
    Esposito S.
    Blasi F.
    Allegra L.
    Principi N.
    Mowgli Study Group T.
    European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 (9) : 647 - 650
  • [22] Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
    Mulholland, Selamawit
    Gavranich, John B.
    Chang, Anne B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (07):
  • [23] The impact of antimicrobial resistance: Changing epidemiology of community-acquired respiratory-tract infections
    Jones, RN
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 : S4 - S11
  • [24] Serological and molecular detection of Mycoplasma pneumoniae in children with community-acquired lower respiratory tract infections
    Kumar, Surinder
    Garg, Indu Bala
    Sethi, G. R.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (01) : 5 - 9
  • [25] Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia
    Altraja, A.
    Naaber, P.
    Tamm, E.
    Meriste, S.
    Kullamaa, A.
    Leesik, H.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (06) : 603 - 609
  • [26] Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections
    Kumar, Surinder
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2018, 147 : 23 - 31
  • [27] Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States
    Biedenbach, Douglas J.
    Jones, Ronald N.
    Fritsche, Thomas R.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 61 (02) : 240 - 244
  • [28] Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program
    Zhang, Yawei
    Zhang, Feifei
    Wang, Hui
    Zhao, Chunjiang
    Wang, Zhanwei
    Cao, Bin
    Du, Yan
    Feng, Xianju
    Hu, Yunjian
    Hu, Bijie
    Ji, Ping
    Liu, Zhiyong
    Liu, Yong
    Liao, Wanzhen
    Lu, Juan
    Sun, Hongli
    Wang, Zhongxin
    Xu, Xiuli
    Xu, Xuesong
    Yang, Qing
    Yu, Yunsong
    Zhang, Rong
    Zhuo, Chao
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2016, 5 : 36 - 41
  • [29] Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?
    Marchese, Anna
    Esposito, Susanna
    Barbieri, Ramona
    Bassetti, Matteo
    Debbia, Eugenio
    BMC INFECTIOUS DISEASES, 2012, 12
  • [30] What is the Place of Fluoroquinolones in the Treatment of Community-Acquired Respiratory Tract Infections?
    Hervé Momméja-Marin
    Claude Carbon
    Drugs, 1999, 57 : 851 - 853